Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET TrialStephen Johnston, Samuel A. Jacobs, Duncan Wheatley et al.|Journal of Clinical Oncology|2018Cited by 233
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutationsRekha Pal, Katherine L. Pogue–Geile|PLoS ONE|2018Cited by 11